Advanced Medical Solutions Group (LON:AMS) Shares Cross Above 200-Day Moving Average - Time to Sell?

Key Points

• Price action: AMS shares crossed above their 200-day moving average (200‑day MA GBX 213.04), trading as high as GBX 223.50 and last at GBX 222 on a volume of 2,082,663 shares.
• Analyst view: Consensus is a "Moderate Buy" with three Buys and one Hold, and an average price target of GBX 270.25 (notable targets: Berenberg GBX 300, RBC GBX 260).
• Fundamentals: Market cap ~£480.4M, high valuation (PE 49.12, PEG 5.00) but strong liquidity (quick ratio 4.58, current ratio 2.79) and modest leverage (debt/equity 31.5%).

Advanced Medical Solutions Group plc (LON:AMS - Get Free Report) shares crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 213.04 and traded as high as GBX 223.50. Advanced Medical Solutions Group shares last traded at GBX 222, with a volume of 2,082,663 shares changing hands.

Wall Street Analysts Forecast Growth

Several analysts have commented on AMS shares. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 300 price objective on shares of Advanced Medical Solutions Group in a research report on Wednesday, March 18th. Royal Bank Of Canada reissued a "sector perform" rating and set a GBX 260 target price on shares of Advanced Medical Solutions Group in a research report on Thursday, April 9th. Three analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of GBX 270.25.

Advanced Medical Solutions Group Price Performance

The business's 50 day moving average is GBX 204.69 and its two-hundred day moving average is GBX 213.04. The company has a debt-to-equity ratio of 31.50, a quick ratio of 4.58 and a current ratio of 2.79. The firm has a market capitalization of £480.42 million, a PE ratio of 49.12, a price-to-earnings-growth ratio of 5.00 and a beta of 0.63.

Advanced Medical Solutions Group (LON:AMS - Get Free Report) last posted its earnings results on Wednesday, March 18th. The company reported GBX 11.98 earnings per share (EPS) for the quarter. Advanced Medical Solutions Group had a return on equity of 3.87% and a net margin of 4.35%. Equities research analysts anticipate that Advanced Medical Solutions Group plc will post 9.8159509 earnings per share for the current fiscal year.

About Advanced Medical Solutions Group

AMS is a world-leading independent developer and manufacturer of innovative tissue-healing technology, focused on quality outcomes for patients and value for payers. AMS has a wide range of surgical products including tissue adhesives, sutures, haemostats, internal fixation devices and internal sealants, which it markets under its brands LiquiBand®, RESORBA®, LiquiBandFix8®, and Seal-G®. AMS also supplies wound care dressings such as silver alginates, alginates and foams through its ActivHeal® brand as well as under white label.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.